Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway-Related Genes in Lung Cancers

Abstract

Background. Mitochondria are the energy factories of cells. The abnormality of mitochondrial energy metabolism pathways is closely related to the occurrence and development of lung cancer. The abnormal genes in mitochondrial energy metabolism pathways might be the novel targets and biomarkers to diagnose and treat lung cancers. Method. Genes in major mitochondrial energy metabolism pathways were obtained from the KEGG database. The transcriptomic, mutation, and clinical data of lung cancers were obtained from The Cancer Genome Atlas (TCGA) database. Genes and clinical biomarkers were mined that affected lung cancer survival. Gene enrichment analysis was performed with ClusterProfiler and the gene set enrichment analysis (GSEA). STRING database and Cytoscape were used for protein-protein interaction (PPI) analysis. The diagnostic biomarker pattern of lung cancer was optimized, and its accuracy was verified with 10-fold cross-validation. The four genes screened by logistic regression model were verified by western blot in 5 pairs of lung cancer specimens collected in hospital. Results. In total, 188 mitochondrial energy metabolism pathway-related genes (MMRGs) were included in this study. GSEA analysis found that MMRGs in the lung cancer group were mainly enriched in the metabolic pathway of oxidative phosphorylation and electron respiratory transport chain compared to the control group. Age did not affect the mutation frequency of MMRGs. Comparative analysis of these 188 MMRGs identified 43 differentially expressed MMRGs (24 upregulated and 19 downregulated) in the lung cancer group compared to the control group. The survival analysis of these 43 differentially expressed MMRGs found that the survival time was better in the low-expressed GAPDHS group than that in the high-expressed GAPDHS group of lung cancers. The advanced age, high expression of GAPDHS, low expressions of ACSBG1 and CYP4A11, and ACOX3 mutation were biomarkers of poor prognosis in lung cancers. PPI analysis showed that proteins such as GAPDH and GAPDHS interacted with many proteins in mitochondrial metabolic pathways. A four-MMRG-signature model ( y = 0.0069 ∗ ACADL − 0.001 ∗ ALDH 18 A 1 − 0.0405 ∗ CPT 1 B + 0.0008 ∗ PPARG − 1.625 ) was established to diagnose lung cancer with the accuracy up to 98.74%, AUC value up to 0.992, and a missed diagnosis rate of only 0.6%. Western blotting showed that ALDH18A1 and CPT1B proteins were significantly overexpressed in the lung cancer group ( p < 0.05 ), and ACADL and PPARG proteins were slightly underexpressed in the lung cancer group ( p < 0.05 ), which were consistent with the results of their corresponding mRNA expressions. Conclusion. Mitochondrial energy metabolism pathway alterations are the important hallmarks of lung cancer. Age did not increase the risk of MMRG mutation. High expression of GAPDHS, low expression of ACSBG1, low expression of CYP4A11, mutated ACOX3, and old age predict a poor prognosis of lung cancer. Four differentially expressed MMRGs (ACADL, ALDH18A1, CPT1B, and PPARG) established a logistic regression model, which could effectively diagnose lung cancer. At the protein level, ALDH18A1 and CPT1B were significantly upregulated, and ACADL and PPARG were slightly underexpressed, in the lung cancer group compared to the control group, which were consistent with the results of their corresponding mRNA expressions.

Development of a Hallmark Pathway-Related Gene Signature Associated with Immune Response for Lower Grade Gliomas

“…The STING pathway develops anti-tumor activity through tumor-originated DNA reacting and T cell activating [ 17 ]. Although some useful pathway-related signatures were utilized to predict the prognosis of cancer patients, few studies integrated these signaling pathways with the immune microenvironment [ 18 , 19 , 20 ]. Therefore, it is necessary to construct a pathway-related signature to predict the LGG patients’ prognosis and to improve their responses to therapies.…”

Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis

“…ACOX3, an acyl-CoA oxidase, is known to be involved in peroxisomal branched-chain fatty acid β-oxidation. Although ACOX3 is highly expressed in human prostate cancer tissue compared with paired normal tissues, very low levels of expression are shown in other organs [ 76 , 77 ]. Interestingly, the prognostic role of ACOX3 in breast cancer as well as other cancers is unclear.…”

An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration

“…ACADL can inhibit the proliferation of hepatocellular carcinoma tumor cells through Hippo/YAP signaling ( 39 ). ALDH4A1 is downregulated in lung cancer and is an important biomarker for differentiating lung cancer tumor tissue from normal tissue ( 22 ). These studies indicated that the genes used to construct risk models were associated with tumors, and therefore, our risk model was a tumor-associated risk model.…”

“…The summary and collection of complete MMRGs refer to the research of Ye et al. ( 22 ). The R-package limma was used to analyze MMRGs that were differentially expressed in normal and tumor tissues and to map the genes used to build risk models in the volcano map.…”